BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression.
Kong Y, Lan T, Wang L, Gong C, Lv W, Zhang H, Zhou C, Sun X, Liu W, Huang H, Weng X, Cai C, Peng W, Zhang M, Jiang D, Yang C, Liu X, Rao Y, Chen C.
Kong Y, et al. Among authors: weng x.
Oncogene. 2024 Sep;43(39):2914-2926. doi: 10.1038/s41388-024-03121-1. Epub 2024 Aug 20.
Oncogene. 2024.
PMID: 39164524
Free PMC article.